Recent Quotes (30 days)

You have no recent quotes
chg | %

Premaitha Health PLC news

   Watch this stock
Showing stories 1 - 10 of about 80   

Articles published

NIPT 11.14 +0.02 (0.17%)
price chart
Premaitha Health PLC 53.2% Potential Upside Indicated by finnCap
Premaitha Health PLC with EPIC/TICKER LON:NIPT had its stock rating noted as 'Retains' with the recommendation being set at 'CORPORATE' this morning by analysts at finnCap.
Premaitha Health PLC (NIPT) Receives Corporate Rating from FinnCap  The Cerbat Gem
finnCap announced Premaitha Health Plc (LON:NIPT), keeping its stock price ...  Breaking Finance News
Premaitha Health PLC 86.9% Potential Upside Indicated by finnCap
Premaitha Health PLC using EPIC/TICKER code LON:NIPT has had its stock rating noted as 'Retains' with the recommendation being set at 'CORPORATE' today by analysts at finnCap.
Premaitha Health PLC (NIPT) Earns “Corporate” Rating from FinnCap  BNB Daily (blog)
Premaitha Health PLC (NIPT) Stock Rating Reaffirmed by FinnCap  The Cerbat Gem
Premaitha welcomes government decision on prenatal tests
Premaitha Health PLC (LON:NIPT) has welcomed a decision by the UK Department of Health to make non-invasive prenatal tests (NIPTs) routinely available on the NHS to high risk pregnant women across the UK.
The Premaitha Health PLC (NIPT) Receives Corporate Rating from FinnCap
Premaitha Health PLC (LON:NIPT)'s stock had its “corporate” rating reissued by stock analysts at FinnCap in a research note issued on Monday.
FinnCap Indicates Potential 61.8% Increase In Shares Of Premaitha Health Plc  Fiscal Standard
Premaitha Health
Premaitha Health is a molecular diagnostics company employing next generation DNA analysis technology to develop, manufacture and sell molecular diagnostic products intended to have a major beneficial impact on human health. Premaitha is responsible ...
Premaitha Health PLC (NIPT) Rating Reiterated by FinnCap
Premaitha Health PLC (LON:NIPT)'s stock had its “corporate” rating reissued by analysts at FinnCap in a research note issued on Monday.
Premaitha Health PLC - Receive News & Ratings Daily  BBNS
Premaitha Health PLC (NIPT) Given “Corporate” Rating at FinnCap  Community Financial News
SMALL CAP IDEAS: Premaitha Health builds foundations for successful European ...
Very often investors are asked to commit to the long haul when they buy into the latest new thing in the healthcare sector.
Premaitha Health to join AIM as it prepares to launch first product
Subject to ViaLogy shareholders approval later this month, the enlarged business will be re-named Premaitha Health PLC and will become a listed company on the AIM platform.
ViaLogy Buys Molecular Diagnostic Company, But Struggles To Sell Energy Unit  London South East
Related articles »  
Premaitha Health signs Investment Agreement with Thermo Fisher Scientific
Premaitha's CE-marked, non-invasive prenatal screening (NIPT) product, the IONA� test, runs on Thermo Fisher's two sequencing instruments, the Ion Proton and Ion Chef.
The Premaitha Health PLC (NIPT) Rating Reiterated by FinnCap
Premaitha Health PLC (LON:NIPT)'s stock had its “corporate” rating reaffirmed by equities researchers at FinnCap in a report issued on Tuesday.